Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jan 27, 2024; 16(1): 103-112
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.103
Table 4 Univariate analysis of recurrence of common bile duct stones after endoscopic retro-grade cholangiopancreatography
Variables

Non-recurrent group (n = 72)
Recurrent group (n = 28)
χ2 value
P value
Age (yr, mean ± SD)54.64 ± 6.6251.43 ± 8.74-1.9830.050
Gender, n (%)Male31 (43.06)13 (46.43)0.0930.760
Female41 (56.94)15 (53.57)
Jaundice, n (%)Yes19 (26.39)8 (28.57)0.0490.825
No53 (73.61)20 (71.43)
Hypertension, n (%)Yes18 (25.00)8 (28.57)0.1340.715
No54 (75.00)20 (71.43)
Diabetes, n (%)Yes27 (37.50)5 (17.86)3.5750.059
No45 (62.50)23 (82.14)
History of biliary tract surgery, n (%)Yes12 (16.67)2 (7.14)1.5190.218
No60 (83.33)26 (92.86)
Parapillary diverticulum, n (%)Yes18 (25.00)18 (64.29)13.504< 0.001
No54 (75.00)10 (35.71)
No. of stones, n (%)≤ 346 (63.89)11 (39.29)4.9790.026
> 326 (36.11)17 (60.71)
Bile culture positive, n (%)19 (26.39)18 (64.29)12.421< 0.001
Postoperative treatment, n (%)Control26 (36.11)21 (75.00)12.240< 0.001
UDCA46 (63.89)7 (25.00)
Common bile duct diameter(mm), median (P25, P75)14.00 (12.00, 15.00)16.00 (14.00, 17.00)-3.2650.001
Maximum stone diameter(mm), median (P25, P75)12.00 (11.25, 13.75)15.00 (12.00, 16.00)-3.599< 0.001
ERCP time (min, mean ± SD)63.93 ± 5.1265.82 ± 5.331.6400.140
WBC (× 109/L, mean ± SD)6.45 ± 1.056.38 ± 1.27-0.2900.772
PCT (ng/mL), median (P25, P75)0.18 (0.12, 0.27)0.18 (0.12, 0.28)-0.0880.930
TBiL (μmon/L, mean ± SD)97.85 ± 10.9597.32 ± 12.43-0.2110.833
DBiL (μmon/L, mean ± SD)64.13 ± 7.6462.02 ± 7.76-1.2340.220
GGT (U/L, mean ± SD)330.90 ± 19.82325.88 ± 21.99-1.1020.273
ALT (U/L, mean ± SD)272.31 ± 22.87269.09 ± 24.88-0.6170.538
ALP (U/L, mean ± SD)259.81 ± 25.79259.36 ± 23.50-0.0790.937
AST (U/L, mean ± SD)201.12 ± 16.02201.44 ± 15.550.0890.929